HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block.

Abstract
The prevalence of autoantibodies to ribonucleoprotein antigens in cases of congenital heart block was established using immunofluorescence, counterimmunoelectrophoresis, double immunodiffusion and Western blots. All of 35 mothers of babies with congenital heart block, none of five mothers of babies with other types of heart block, 10 of 29 women with connective tissue disease but no babies with heart block, four of 445 normal pregnant women and two of 109 healthy nonpregnant women had either Ro (SS-A) or La (SS-B) antibodies. Of 15 babies with congenital heart block, 10 of 10 who were less than 3 months old possessed antibody. Antibody titres in affected but not in normal infants were lower compared with their mothers' titres, suggesting deposition of antibodies in the baby's tissues. The findings indicate that placental transfer of anti-Ro (SS-A) or anti-La (SS-B) is essential for development of congenital complete heart block.
AuthorsP V Taylor, K F Taylor, A Norman, S Griffiths, J S Scott
JournalBritish journal of rheumatology (Br J Rheumatol) Vol. 27 Issue 2 Pg. 128-32 (Apr 1988) ISSN: 0263-7103 [Print] England
PMID3284603 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antinuclear
  • Ribonucleoproteins
  • SS-A antibodies
  • SS-B antibodies
Topics
  • Antibodies, Antinuclear (analysis)
  • Counterimmunoelectrophoresis
  • Female
  • Fluorescent Antibody Technique
  • Heart Block (congenital, immunology)
  • Humans
  • Infant
  • Maternal-Fetal Exchange
  • Pregnancy
  • Pregnancy Outcome
  • Ribonucleoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: